Browsing Centre for Clinical Pharmacology by Subject "Primary percutaneous coronary intervention"
Now showing items 1-4 of 4
-
A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial
(Oxford University Press, 2016-01-14)Clinical trials suggest that intracoronary delivery of autologous bone marrow-derived cells (BMCs) 1–7 days post-acute myocardial infarction (AMI) may improve left ventricular (LV) function. Earlier time points have not ...